FrailtyNCT06343168
Prevalence of Frailty and Associated Factors in Coronary Artery Bypass Patients
An observational study of Frailty, run by Uşak University at 1 site in Turkey (Türkiye).
Trial summary
This study aimed to determine the prevalence of and factors affecting frailty in patients with coronary artery bypass graft. The main question it aims to answer are: What are the prevalence of and factors affecting frailty in patients with coronary artery bypass graft Type of study: descriptive cross-sectional study… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Frailty
- What is being tested?
- prevalence of frailty
- How many people
- 96 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 18 Feb 2021to 18 Feb 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: coronary artery bypass grafting patients
Who may be able to join
- 18 years and older
- planned CABG surgery
- volunteer to participate in the study
Who cannot join
- limb amputations
- stroke-related sequela
- hearing problems
- clinically unstable
Trial locations and contacts
1 site in 1 country.
About this study
This study aimed to determine the prevalence of and factors affecting frailty in patients with coronary artery bypass graft.
The main question it aims to answer are:
What are the prevalence of and factors affecting frailty in patients with coronary artery bypass graft Type of study: descriptive cross-sectional study Participant population: coronary artery bypass grafting patients
- Conditions
- Frailty
- Being tested
- prevalence of frailty
- Medical subject headings
- Frailty
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
prevalence of frailtyOther
determine the prevalence of frailty
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of frailty
Modified Fried Frailty Index
Measured: Preoperative
Secondary outcomes (4)
Activities of Daily Living
Barthel Activities of Daily Living Index
Measured: Preoperative
Nutritional Assessment
Mini Nutritional Assessment Test-Short Form
Measured: Preoperative
Comorbidity
Charlson Comorbidity Index
Measured: Preoperative
Cognitive Assessment
Montreal Cognitive Assessment
Measured: Preoperative
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Apr 2024
- Study start18 Feb 2021
- Primary completion18 Feb 2022
- Study completion18 Feb 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for FrailtyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 96 participants (actual)
Sponsor and investigators
- Lead sponsor
- Uşak University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06343168
- Sponsor's protocol ID
- frailty
- Status last verified
- Mar 2024
- First submitted
- 26 Mar 2024
- Last updated
- 2 Apr 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of Frailty and Associated Factors in Coronary Artery Bypass Patients
- ClinicalTrials.gov ID
- NCT06343168
- Acronym / sponsor ID
- frailty
- Conditions
- Frailty
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 96 participants (actual)
- Lead sponsor
- Uşak UniversityUniversity, hospital or other
- Study start
- 18 Feb 2021 (actual)
- Primary completion
- 18 Feb 2022 (actual)
- Study completion
- 18 Feb 2022 (actual)
- First posted
- 2 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aimed to determine the prevalence of and factors affecting frailty in patients with coronary artery bypass graft.
The main question it aims to answer are:
What are the prevalence of and factors affecting frailty in patients with coronary artery bypass graft Type of study: descriptive cross-sectional study Participant population: coronary artery bypass grafting patients
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- coronary artery bypass grafting patients
Key inclusion criteria (3 listed)
- 18 years and older
- planned CABG surgery
- volunteer to participate in the study
Key exclusion criteria (4 listed)
- limb amputations
- stroke-related sequela
- hearing problems
- clinically unstable
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| prevalence of frailtydetermine the prevalence of frailty | Other | – |
Primary outcome
Prevalence of frailty
Time frame: Preoperative
Modified Fried Frailty Index
4 secondary outcomes
Activities of Daily Living
Time frame: Preoperative
Nutritional Assessment
Time frame: Preoperative
Comorbidity
Time frame: Preoperative
Cognitive Assessment
Time frame: Preoperative
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Apr 2024.
Related trials for Frailty
Enrolling by invitation
Online Exercise Program for Transplant Patients: A Pilot Study
Kidney Transplantation, Physical Function
Recruiting
Comparıson of the Effıcacy of Conventıonal Exercıse and Pılates ın Pre-fraıl and Fraıl Older Adults
Frailty Syndrome, Prefrail Elderly
Not yet recruiting
Adapting an Evidence-Based Physical Activity Intervention to Prevent Frailty and Functional Decline in Older Women Living With HIV
Mobility Impairment, Frailty
Recruiting
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
Mobility Limitation, Frailty
Not yet recruiting
Virtual Reality Multidomain Training for Older Adults With Cognitive Frailty
Cognitive Frailty
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Frailty, run by Uşak University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of frailty (time frame: Preoperative). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Apr 2024.